(Q42796876)

English

Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne.

scientific article published on December 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21091683

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21091683%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

title

Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21091683

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21091683%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21091683

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21091683%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

author name string

Ahmet Akar

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21091683

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21091683%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

Ibrahim Ozmen

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21091683

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21091683%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

Hakan Erbil

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21091683

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21091683%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

publication date

1 December 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21091683

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21091683%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

published in

International Journal of Dermatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21091683

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21091683%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

volume

49

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21091683

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21091683%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21091683

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21091683%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

page(s)

1440-1444

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21091683

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21091683%20AND%20SRC:MED&resulttype=core&format=json

(Q42796876)

Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)